Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > one of next 8 trading day will

<< Previous

Bullboard Posts

Next >>

Comment by ForexWhaleon Nov 20, 2018 3:51pm

76 Views

Post# 29001435

RE:one of next 8 trading day will

Doubt we will have any movement with Q3 results. Everyone knows there financial situation and update as given in last NR.

Phase 2 financing deal is going to be annouced late Q4 as was written in last NR so that is what will make it move to 18-20 cent range. Need to be patient.

Encouraging that its not going down as overall stocks got badly hit today. Holding is the best starategy for now.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale